Five-year survival decreases over time in patients with BRCA-mutated ovarian cancer: a systemic review and meta-analysis
Five-year survival decreases over time in patients with BRCA-mutated ovarian cancer: a systemic review and meta-analysis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Five-year survival decreases over time in patients with BRCA-mutated ovarian cancer: a systemic review and meta-analysis have?
Five-year survival decreases over time in patients with BRCA-mutated ovarian cancer: a systemic review and meta-analysis has 13 citations in the OpenAlex counts ScholarIQ stores.
When was Five-year survival decreases over time in patients with BRCA-mutated ovarian cancer: a systemic review and meta-analysis published?
Five-year survival decreases over time in patients with BRCA-mutated ovarian cancer: a systemic review and meta-analysis has 2020 year in the ScholarIQ index.
What is the open-access status of Five-year survival decreases over time in patients with BRCA-mutated ovarian cancer: a systemic review and meta-analysis?
Five-year survival decreases over time in patients with BRCA-mutated ovarian cancer: a systemic review and meta-analysis has closed oa status in the ScholarIQ index.
What is the DOI of Five-year survival decreases over time in patients with BRCA-mutated ovarian cancer: a systemic review and meta-analysis?
The DOI for Five-year survival decreases over time in patients with BRCA-mutated ovarian cancer: a systemic review and meta-analysis is on the source record.
What is the PMID of Five-year survival decreases over time in patients with BRCA-mutated ovarian cancer: a systemic review and meta-analysis?
The PMID for Five-year survival decreases over time in patients with BRCA-mutated ovarian cancer: a systemic review and meta-analysis is on the source record.
What is the OpenAlex record for Five-year survival decreases over time in patients with BRCA-mutated ovarian cancer: a systemic review and meta-analysis?
The OpenAlex for Five-year survival decreases over time in patients with BRCA-mutated ovarian cancer: a systemic review and meta-analysis is on the source record.